Dextromethorphan Hydrobromide And Promethazine Hydrochloride
NDC Package 17856-0604-4
Package Information
Dextromethorphan Hydrobromide And Promethazine Hydrochloride is promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-0604 and is authorized under FDA application ANDA088864.
Identification & Billing
- RxCUI: 991528 - promethazine HCl 6.25 MG / dextromethorphan HBr 15 MG in 5 mL Oral Solution
- RxCUI: 991528 - dextromethorphan hydrobromide 3 MG/ML / promethazine hydrochloride 1.25 MG/ML Oral Solution
- RxCUI: 991528 - dextromethorphan HBr 15 MG / promethazine HCl 6.25 MG per 5 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17856 - Atlantic Biologicals Corp.
- 17856-0604 - Dextromethorphan Hydrobromide And Promethazine Hydrochloride
- 17856-0604-4 - 72 CUP in 1 BOX / 5 mL in 1 CUP (17856-0604-5)
- 17856-0604 - Dextromethorphan Hydrobromide And Promethazine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17856-0604-4 identifies a specific commercial package of 72 cup in 1 box / 5 ml in 1 cup (17856-0604-5) of Dextromethorphan Hydrobromide And Promethazine Hydrochloride, labeled by Atlantic Biologicals Corp.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atlantic Biologicals Corp. on January 04, 1985. The current certification is valid through December 31, 2025.
How is this Atlantic Biologicals Corp. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856060404. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.